R
SYNTHETIC COMMUNICATIONSV
7
References
[1] Chen, C.-Y.; Lee, P.-H.; Lin, Y.-Y.; Yu, W.-T.; Hu, W.-P.; Hsu, C.-C.; Lin, Y.-T.; Chang,
L.-S.; Hsiao, C.-T.; Wang, J.-J.; et al. Synthesis, DNA-Binding Abilities and Anticancer
Activities of Triazole-Pyrrolo[2,1-c][1,4]Benzodiazepines Hybrid Scaffolds. Bioorganic
[2] Zhao, M.-N.; Liang, H.; Ren, Z.-H.; Guan, Z.-H. Iron-Catalyzed Tandem One-Pot
Addition and Cyclization of the Blaise Reaction Intermediate and Nitroolefins: Synthesis
of Substituted NH-Pyrroles from Nitriles. Adv. Synth. Catal. 2013, 355, 221–226. DOI:
[3] Kamal, A.; Prabhakar, S.; Janaki Ramaiah, M.; Venkat Reddy, P.; Ratna Reddy, C.;
Mallareddy, A.; Shankaraiah, N.; Lakshmi Narayan Reddy, T.; Pushpavalli, S. N. C. V. L.;
Pal-Bhadra, M. Synthesis and Anticancer Activity of Chalcone-Pyrrolobenzodiazepine
Conjugates Linked via 1,2,3-Triazole Ring Side-Armed with Alkane Spacers. Eur. J. Med.
[4] Kamal, A.; Shankaraiah, N.; Devaiah, V.; Laxma Reddy, K.; Juvekar, A.; Sen, S.; Kurian,
N.; Zingde, S. Synthesis of 1,2,3-Triazole-Linked Pyrrolobenzodiazepine Conjugates
Employing ‘Click’ Chemistry: DNA-Binding Affinity and Anticancer Activity. Bioorg. Med.
[5] Hou, J.; Liu, X.; Shen, J.; Zhao, G.; Wang, P. G. The Impact of Click Chemistry in
Medicinal Chemistry. Expert Opin. Drug Discov. 2012, 7, 489–501. DOI: 10.1517/
[6] Shankaraiah, N.; Jadala, C.; Nekkanti, S.; Senwar, K. R.; Nagesh, N.; Shrivastava, S.; Naidu,
V. G. M.; Sathish, M.; Kamal, A. Design and Synthesis of C3-Tethered 1,2,3-Triazolo-
b-Carboline Derivatives: Anticancer Activity, DNA-Binding Ability, Viscosity and
Molecular Modeling Studies. Bioorg. Chem. 2016, 64, 42–50. DOI: 10.1016/
[7] Thirumurugan, P.; Matosiuk, D.; Jozwiak, K. Click Chemistry for Drug Development and
Diverse Chemical–Biology Applications. Chem. Rev. 2013, 113, 4905–4979. DOI: 10.1021/
[8] Wang, K.; Chen, M.; Wang, Q.; Shi, X.; Lee, J. K. 1,2,3-Triazoles: Gas Phase Properties.
[9] Lau, Y. H.; Rutledge, P. J.; Watkinson, M.; Todd, M. H. Chemical Sensors That
Incorporate Click-Derived Triazoles. Chem. Soc. Rev. 2011, 40, 2848–2866. DOI: 10.1039/
[10] Kharb, R.; Sharma, P. C.; Yar, M. S. Pharmacological Significance of Triazole Scaffold.
[11] Kallander, L. S.; Lu, Q.; Chen, W.; Tomaszek, T.; Yang, G.; Tew, D.; Meek, T. D.;
Hofmann, G. A.; Schulz-Pritchard, C. K.; Smith, W. W.; et al. 4-Aryl-1,2,3-Triazole: A
Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized to
Inhibit Angiogenesis in Vivo. J. of Med. Chem. 2005, 48, 5644–5647. DOI: 10.1021/
€
[12] RoHrig, U. F.; Awad, L.; Grosdidier, A.; Larrieu, P.; Stroobant, V.; Colau, D.; Cerundolo,
V.; Simpson, A. J. G.; Vogel, P.; Van den Eynde, B. J.; et al. Rational Design of
Indoleamine 2,3-Dioxygenase Inhibitors. J. Med. Chem. 2010, 53, 1172–1189. DOI:
[13] Ma, Q.; Qi, S.; He, X.; Tang, Y.; Lu, G. 1,2,3-Triazole Derivatives as Corrosion Inhibitors
for Mild Steel in Acidic Medium: Experimental and Computational Chemistry Studies.
[14] Hein, J. E.; Fokin, V. V. Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) and
Beyond: New Reactivity of Copper(I) Acetylides. Chem. Soc. Rev. 2010, 39, 1302–1315.
[15] Cai, Z.-J.; Lu, X.-M.; Zi, Y.; Yang, C.; Shen, L.-J.; Li, J.; Wang, S.-Y.; Ji, S.-J. I2/TBPB
Mediated Oxidative Reaction of N-Tosylhydrazones with Anilines: Practical Construction